TalkMed Group (SGX:5G3) received a privatization offer from TW Troy through a scheme arrangement priced at SG$0.456 per share, according to a filing with the Singapore Exchange on Monday.
The company's issued and paid up share capital is SG$27.7 million, comprising 1,329,138,271 shares.
TW Troy is a special purpose vehicle established by oncology group, Tamarind Health.
The proposed acquisition is expected to provide customers of both companies with a "wider range of services and expertise under a combined entity," according to the filing.
Following the completion of the scheme of arrangement, the company will be delisted and removed from the official list of the SGX.
Shares of the medical services provider surged nearly 6% in recent trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。